Risk of Prostate Cancer–related Death Following a Low PSA Level in the PLCO Trial

Volume: 13, Issue: 4, Pages: 367 - 376
Published: Apr 1, 2020
Abstract
Longer-than-annual screening intervals have been suggested to improve the balance of benefits and harms in prostate cancer screening. Many researchers, societies, and guideline committees have suggested that screening intervals could depend on the prostate-specific antigen (PSA) result. We analyzed data from men (N = 33,897) ages 55–74 years with a baseline PSA test in the intervention arm of the Prostate, Lung, Colorectal and Ovarian Cancer...
Paper Details
Title
Risk of Prostate Cancer–related Death Following a Low PSA Level in the PLCO Trial
Published Date
Apr 1, 2020
Volume
13
Issue
4
Pages
367 - 376
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.